Adjuvant ADT May Up Mortality in Black Prostate Cancer Patients
Androgen deprivation increased all-cause mortality risk by 77% among black men who underwent brachytherapy for favorable-risk prostate cancer.
Diagnosis & Disease Information
Factors Affecting Post-Brachytherapy Urinary Incontinence Type ID’d
TURP and EBRT after seed implantation are associated with development of urge urinary incontinence.
Bladder Cancer Risk Higher Following Prostate Radiotherapy
The increased risk occurs more than 10 years after treatment and most pronounced in men who undergo brachytherapy.
Erectile Function Preserved in Half of Men Receiving Brachytherapy
Potency is preserved in 50.4% and 60.8% of patients at 10 years after seed implantation, according to MSSFI and SHIM scores, respectively.
Iodine-125 Interstitial Implant Possible for Low-risk Prostate Cancer
Findings based on 10-year follow-up of localized prostate cancer patients.
Modest Survival Benefit with EBRT + Brachytherapy in Intermediate PCa
Combined radiotherapy remains controversial due to the increased potential for toxicities.
Post-Brachytherapy PSA Bounce Linked to Intercourse Satisfaction
Researchers say they believe study findings support a hypothesis than ejaculation resulting from sexual intercourse might cause PSA bounce.
Salvage Cryo Outcomes Similar After EBRT, Brachytherapy
Study reveals comparable rates of freedom from biochemical failure at 5 years.
Low-dose Brachytherapy Provides Better Outcomes in Intermediate PCa
Low-dose-rate brachytherapy boost (LDR-PB) achieves better rates of biochemically disease-free outcomes in prostate cancer.
Has the proportion of your patients undergoing prostate brachytherapy been declining?
Prostate cancer patients undergoing radical prostatectomy increased by double digits while those undergoing brachytherapy decreased.
- Loading...
Loading...
Next post in Physician Polls
Loading... 
Loading...